OTC:ACAT | Cash Flow Statement | NP Life Sciences Health Industry Group Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2023-12-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2023-12-31-$15,355.00-$13,937.00$0.00
2023-09-30-$37,670.00
2023-06-30$71,195.00
2023-03-31$1,222.00$18,219.00
2022-12-31$16,598.00$114,908.00
2022-09-30-$5,440.00
2022-06-30$1,078.00
2022-03-31-$31,092.00-$4,864.00
2021-12-31$32,269.00$2,976.00
2021-09-30-$20,834.00
2021-06-30-$52,743.00
2021-03-31-$24,243.00-$29,184.00
2020-12-31-$21,658.00-$26,383.00
2020-09-30-$25,636.00
2020-06-30-$53,653.00
2020-03-31-$30,122.00-$20,708.00
2019-12-31-$42,322.00$75,138.00$0.00$0.00
2019-09-30-$31,881.00
2019-06-30-$4,950.00
2019-03-31-$29,701.00-$52,121.00-$7,300.00$104,301.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2023-12-31-$2,935.00-$73,607.00$22,362.00
2022-12-31-$18,856.00$93,873.00
2021-12-31-$65,677.00-$90,625.00
2020-12-31-$131,065.00-$124,322.00
2019-12-31-$108,827.00-$4,266.00-$8,600.00$364,426.00